100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Mouse CD274/PD-L1 Antibody [10F.9G2] (AGEL2260)

SKU AGEL2260
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Mouse
Host Species Rat
Isotype Rat IgG2b, κ
Clone 10F.9G2
Conjugation FITC
€57 - €144

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Mouse CD274/PD-L1 Antibody [10F.9G2]

The FITC Anti-Mouse CD274 (PD-L1) Antibody (10F.9G2) (AGEL2260) offered by AssayGenie is a cutting-edge tool designed for researchers studying immune checkpoint proteins in the context of immunotherapy and cancer research. This antibody specifically targets the PD-L1 protein, a key regulator of immune responses, particularly in the suppression of T cell activity.By utilizing this antibody, researchers can effectively detect and analyze PD-L1 expression in mouse samples, enabling detailed investigation into its role in immune evasion mechanisms within the tumor microenvironment. The high specificity and sensitivity of this antibody make it a valuable asset for understanding the interplay between PD-L1 and immune cells, providing crucial insights for the development of novel immunotherapies targeting this pathway.

PD-L1 has emerged as a critical biomarker in cancer immunotherapy, with its overexpression associated with immune evasion and resistance to treatment. By elucidating the intricate mechanisms underlying PD-L1 regulation and function, researchers can pave the way for innovative strategies to enhance the efficacy of immune checkpoint blockade therapies and combat tumor immune evasion mechanisms.In summary, the FITC Anti-Mouse CD274 (PD-L1) Antibody (10F.9G2) (AGEL2260) from AssayGenie offers a potent and reliable tool for investigating the role of PD-L1 in immune modulation and cancer progression, making it an essential resource for researchers dedicated to advancing our understanding of immune checkpoint pathways.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose